Trademarkia Logo

Australia

AU$
LUPKYNIS
Protected: Registered/protected

Last updated on 19 Jul 2021

Owner Info

Aurinia Pharmaceuticals Inc.

1203-4464 Markham Street

Victoria BC V8Z 7X8, CANADA

Serial Number

2146284 filed on 9 Nov 2020

Correspondent

Matthew R. Wilmot Stoel Rives LLP

760 SW Ninth Avenue, Suite 3000,

Portland OR 97205,

UNITED STATES OF AMERICA

LUPKYNIS

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis.

Mark Details


Serial Number

2146284

Registered On

9 Nov 2020

Renewal On

9 Nov 2030

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
19th Jul 2021Customer Amendment Made correspondence sent
19th Jul 2021Amendment to Address for Service Requested
19th Jun 2021International Registration in Australia Protected correspondence sent
18th Jun 2021IP Right Registration Published
18th Jun 2021Status change to Registered/Protected
10th Apr 2021Application Accepted correspondence sent
10th Apr 2021IP Right has been Examined
10th Apr 2021IP Right Acceptance Published
3rd Mar 2021Status change to Accepted
4th Jan 2021Awaiting examination